Physician profile
Harry Schmaltz
NPI 1457388027
$116,033.77
in general payments reported to CMS, 2019-2025
9 companies · $20K in 2025
The $20K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $18K · 2021: $6,928 · 2022: $12K · 2023: $24K · 2024: $9,569 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Consulting Fee: $22K · Travel and Lodging: $6,263 · Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Consulting Fee | $21,605.51 |
| Travel and Lodging | $6,263.14 |
| Food and Beverage | $1,527.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $106,076.00 | 2019-2025 | Oxford, Persona, Affixus |
| Nextstep Arthropedix, LLC | $8,441.03 | 2019-2020 | |
| Medacta USA, INC. | $1,330.81 | 2024 | |
| Molnlycke Health Care US, LLC | $53.93 | 2021 | |
| Stryker Corporation | $40.45 | 2020 | |
| Depuy Synthes Sales INC. | $34.78 | 2023 | Actis |
| Baxter Healthcare | $24.67 | 2025 | Tisseel |
| Kci USA, INC. | $17.12 | 2023 | V.A.C.Ulta, Prevena |
| Solventum Corporation | $14.98 | 2024 | V.A.C.Ulta, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Schmaltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.